- Market Capitalization, $K 123,620
- Shares Outstanding, K 25,808
- Annual Sales, $ 28,800 K
- Annual Income, $ 9,390 K
- 60-Month Beta 1.53
- Price/Sales 4.24
- Price/Cash Flow 8.14
- Price/Book 2.54
|Period||Period Low||Period High||Performance|
| || |
+0.55 (+12.97%)since 07/14/20
| || |
-3.61 (-42.98%)since 05/14/20
| || |
-1.83 (-27.60%)since 08/14/19
AVEO (AVEO) reports a narrower-than-expected loss but misses sales estimates in the second quarter of 2020.
AVEO (AVEO) delivered earnings and revenue surprises of 17.65% and -49.22%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
CAMBRIDGE, Mass. (AP) _ AVEO Pharmaceuticals Inc. (AVEO) on Monday reported a loss of $7.3 million in its second quarter.
--- Preparations Underway to Support Potential Commercial Launch of Tivozanib in the U.S.; New Debt and Equity Financings, Partnership Milestones Potentially Provide for Working Capital into 2022 -
AVEO Oncology (Nasdaq: AVEO) today announced the closing of a tranched, $35 million debt facility with Hercules Capital, Inc. (NYSE: HTGC) and its affiliates. The new facility has a maturity of 36 months,...
AVEO (AVEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AVEO Oncology (Nasdaq: AVEO) today announced that it has earned a $2.8 million development milestone payment from partner Kyowa Kirin Co., Ltd. (Kyowa Kirin). The milestone relates to acceptance by the...
AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten public offering of 9,725,000 shares of its common stock, which includes the partial exercise by the underwriters...
AVEO Oncology (Nasdaq: AVEO) today announced that it has priced its previously announced underwritten public offering of 8,500,000 shares of its common stock at a price to the public of $5.25 per share....
AVEO Oncology (Nasdaq: AVEO) today announced that it has commenced an underwritten public offering of $40.0 million of shares of its common stock. In connection with the offering, AVEO intends to grant...